Fibromyalgia may be Related to Endocannabinoid Deficiency

On December 1, 2003, Ethan B. Russo, a Senior Medical Advisor at GW Pharmaceuticals submitted a study entitled “Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions?” This study examines the concept of clinical endocannabinoid deficiency (CECD). The study reported investigation into the prospect that … Read moreFibromyalgia may be Related to Endocannabinoid Deficiency

Optimization WordPress Plugins & Solutions by W3 EDGE